Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Phys Written Answersrespiratory

Phys Written Answers · respiratory

Solitary Pulmonary Nodule — Written Clinical Reasoning

DCE long-case preparation: structured written reasoning for solitary pulmonary nodule scenarios — the 9 mm solid nodule in a 60-year-old smoker, and the 12 mm part-solid nodule with a 7 mm solid component.

4 min readVerification in progress

Target exams

FRACP DCEMRCP Part 2
On this page
Study tools

Target exams

FRACP DCEMRCP Part 2
Prompt
DCE long-case preparation: structured written reasoning for solitary pulmonary nodule scenarios — the 9 mm solid nodule in a 60-year-old smoker, and the 12 mm part-solid nodule with a 7 mm solid component.

Model answer — Part A: the 9 mm solid nodule in a smoker

Frame the problem first. A 9 mm solid nodule in a 60-year-old heavy smoker sits above the 8 mm band where surveillance alone is no longer the default — this is a risk-stratification and tissue-question scenario, not a watch-and-wait one. My assessment has three aims: establish the temporal behaviour of the nodule, quantify malignancy probability, and choose between PET, biopsy and resection through the MDT [1] [2].

Assessment. History: smoking exposure and quit date, haemoptysis, weight loss, prior malignancy, occupational exposures, family history of lung cancer, and cardiorespiratory fitness that will shape any curative option. Examination: clubbing, supraclavicular nodes, chest signs. My first investigative move costs nothing — I hunt every prior image from every hospital, because a nodule stable for two years ends this workup and a growing one escalates it [1].

Characterise the nodule properly. I want a dedicated thin-section CT chest if the abdominal CT is technically limited, with formal description of margins (spiculation, lobulation), calcification or fat, and exact size — a 9 mm nodule with benign-pattern calcification is a different object from a 9 mm spiculated nodule [1].

Quantify the risk. I calculate rather than gesture: the Brock model combines age, sex, family history, emphysema with size, nodule type, upper-lobe location, spiculation and count. A 9 mm upper-lobe nodule in an older heavy smoker lands at least in the intermediate band — the band where PET-CT and biopsy live; BTS routes Brock probability of 10% or more to PET [2] [4].

Act on the band. Fleischner offers three options above 8 mm — 3-month CT, PET/CT or tissue — and in this patient PET/CT is the sensible referee: it characterises metabolic activity, detects occult nodal and distant disease, and directs the biopsy target. I quote its limits as I order it: sensitivity about 97% and specificity about 78%, falling below 8–10 mm, with false positives from granulomatous inflammation [1] [3].

Tissue if indicated, by the right route. An avid nodule or a high composite probability goes to the lung nodule MDT for biopsy-route selection — CT-guided for an accessible peripheral lesion (pneumothorax roughly one in five, chest drain about 5–7%, quoted to the patient), bronchoscopic if emphysema or a bronchus sign favours the airway, or straight to VATS if probability is high and he is fit [4] [5].

Close the loop. An honest conversation about what a 9 mm nodule means — most are not cancer, and this is how we will be certain; a written plan with dates; smoking-cessation support started now as the highest-yield intervention available [1].

Physician Medicine Pro

Continue reading

You have read the opening of this written answer. The complete unit — every section and its primary-source references — is part of the Physician Medicine fellowship library.

Sign in to continueSee pricing
References6ShowHide
  1. [1]MacMahon H, Naidich DP, Goo JM, et al. Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017 Radiology, 2017.PMID 28240562
  2. [2]McWilliams A, Tammemagi MC, Mayo JR, et al. Probability of cancer in pulmonary nodules detected on first screening CT N Engl J Med, 2013.PMID 24004118
  3. [3]Gould MK, Maclean CC, Kuschner WG, et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis JAMA, 2001.PMID 11180735
  4. [4]Callister ME, Baldwin DR, Akram AR, et al. British Thoracic Society guidelines for the investigation and management of pulmonary nodules Thorax, 2015.PMID 26082159
  5. [5]Heerink WJ, de Bock GH, de Jonge GJ, et al. Complication rates of CT-guided transthoracic lung biopsy: meta-analysis Eur Radiol, 2017.PMID 27108299
  6. [6]Henschke CI, Yankelevitz DF, Mirtcheva R, et al. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules AJR Am J Roentgenol, 2002.PMID 11959700
Physician Medicine Pro

$29/ monthor $279 / year

The complete Physician Medicine library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousRespiratory Investigation — Written Clinical ReasoningrespiratoryNextBreakthrough Cancer Pain AND Opioid Titration — Written Clinical Reasoningoncological